Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 336 M341 M317 M408 M365 M365 M 1.46 B Research & development —————— — Operating income 548 M622 M666 M738 M644 M655 M 2.7 B Non-Operating Income, Total -2 M-3 M2 M-4 M010 M 8 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses -2 M-3 M2 M-4 M010 M 8 M Unusual income/expense —————— — Pretax income 429 M499 M541 M608 M516 M533 M 2.2 B Equity in earnings —————— — Taxes 176 M125 M144 M73 M84 M-320 M -19 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 253 M374 M397 M535 M432 M853 M 2.22 B Discontinued operations —————— — Net income 253 M374 M397 M535 M432 M853 M 2.22 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 253 M374 M397 M535 M432 M853 M 2.22 B Basic earnings per share (Basic EPS) 0.911.341.421.921.563.1 8 Diluted earnings per share (Diluted EPS) 0.91.331.411.911.553.08 7.95 Average basic shares outstanding 280 M279 M278 M279 M277 M275 M — Diluted shares outstanding 282 M281 M281 M281 M279 M277 M — EBITDA 593 M666 M716 M806 M704 M715 M 2.94 B EBIT 548 M622 M666 M739 M644 M655 M 2.7 B Cost of revenue 520 M560 M587 M816 M677 M700 M 2.78 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 45 M44 M50 M67 M60 M60 M 237 M